
1.66 Delayed Data As of Jan 26 | ![]() Today’s Change | 1.38 Today|||52-Week Range 4.32 | +6.41% Year-to-Date |
First Wave (FWBI) IND Filing Under FDA's Review, Stock Up Jan 16 / Zacks.com - Paid Partner Content |
Previous close | 1.75 |
Today’s open | 1.76 |
Day’s range | 1.64 - 1.78 |
Volume | 3,126,679 |
Average volume (3 months) | 5,550,670 |
Market cap | $421.6M |
Earnings growth (last year) | -35.56% |
Earnings growth (this year) | +23.59% |
Earnings growth (next 5 years) | +25.62% |
Revenue growth (last year) | -76.05% |
P/E ratio | NM |
Price/Sales | 587.16 |
Price/Book | 0.92 |
---- | ||
VNDAVanda Pharmaceutical... | +0.02 | +0.26% |
HROWHarrow Health Inc | -0.58 | -3.85% |
STROSutro Biopharma Inc | -0.26 | -3.35% |
Next reporting date | March 15, 2023 |
EPS forecast (this quarter) | -$0.17 |
Annual revenue (last year) | $1.8M |
Annual profit (last year) | -$303.7M |
Net profit margin | -17,109.87% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |